miglitol, an oral hypoglycemic agent. ▪ INDICATIONS: It is used to treat type 2 diabetes mellitus. ▪ CONTRAINDICATIONS: Factors that prohibit its use include known hypersensitivity to miglitol, diabetic ketoacidosis, cirrhosis, inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, and chronic intestinal disease. ▪ ADVERSE EFFECTS: Hepatotoxicity is a life-threatening side effect. Other adverse effects are low iron and rash. Common side effects are abdominal pain, diarrhea, and flatulence.
